Adaptive Biotechnologies Corp - Common Stock (ADPT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2016 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ADPT on Nasdaq
Shares outstanding
151,803,139
Price per share
$18.07
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
150,278,155
Total reported value
$2,440,576,416
% of total 13F portfolios
0%
Share change
+1,507,190
Value change
+$33,609,697
Number of holders
280
Price from insider filings
$18.07
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Adaptive Biotechnologies Corp - Common Stock (ADPT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.9% +17% $194,757,356 +$33,318,016 11,992,448 +21% BlackRock, Inc. 31 Dec 2025
Sumitomo Mitsui Trust Group, Inc. 4.6% $53,981,782 6,833,137 Sumitomo Mitsui Trust Group, Inc. 31 Dec 2024
Nikko Asset Management Americas, Inc. 4.6% $53,981,782 6,833,137 Nikko Asset Management Americas, Inc. 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC 4.3% $49,711,809 6,292,634 Millennium Management LLC 31 Dec 2024
Rubric Capital Management LP 4.1% $72,889,139 6,256,847 Rubric Capital Management LP 30 Jun 2025
ARK Investment Management LLC 2.9% -27% $40,863,635 -$15,506,311 4,398,669 -28% ARK Investment Management LLC 31 May 2025

As of 31 Dec 2025, 280 institutional investors reported holding 150,278,155 shares of Adaptive Biotechnologies Corp - Common Stock (ADPT). This represents 99% of the company’s total 151,803,139 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Adaptive Biotechnologies Corp - Common Stock (ADPT) together control 73% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VIKING GLOBAL INVESTORS LP 20% 29,993,708 0% 1.3% $487,097,818
BlackRock, Inc. 8.8% 13,333,559 -0.18% 0% $216,536,989
VANGUARD GROUP INC 7.4% 11,282,152 +0.06% 0% $183,222,148
PRICE T ROWE ASSOCIATES INC /MD/ 2.9% 4,387,361 +303% 0.01% $71,252,000
WESTFIELD CAPITAL MANAGEMENT CO LP 2.7% 4,060,481 0.27% $65,942,211
GEODE CAPITAL MANAGEMENT, LLC 2.3% 3,511,855 +3.3% 0% $57,040,977
STATE STREET CORP 2.1% 3,181,644 +3.3% 0% $51,669,899
Invesco Ltd. 2% 3,107,653 +249% 0.01% $50,468,285
LORD, ABBETT & CO. LLC 2% 3,080,759 +151% 0.15% $50,032,000
GOLDMAN SACHS GROUP INC 1.9% 2,902,269 +54% 0.01% $47,132,848
Driehaus Capital Management LLC 1.8% 2,760,387 -8.6% 0.3% $44,828,685
JENNISON ASSOCIATES LLC 1.8% 2,674,668 +104% 0.03% $43,436,609
AMERIPRISE FINANCIAL INC 1.7% 2,590,984 -57% 0.01% $42,077,600
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.6% 2,422,089 -0.79% 0.02% $39,334,725
FRED ALGER MANAGEMENT, LLC 1.5% 2,245,418 -11% 0.14% $36,465,588
WELLINGTON MANAGEMENT GROUP LLP 1.4% 2,165,327 +332% 0.01% $35,164,911
ARK Investment Management LLC 1.4% 2,138,960 -32% 0.23% $34,736,718
Sumitomo Mitsui Trust Group, Inc. 1.3% 1,947,963 -47% 0.02% $31,634,919
Amova Asset Management Americas, Inc. 1.3% 1,947,963 -47% 0.37% $31,615,439
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1.3% 1,940,376 0% 0.05% $31,512,000
D. E. Shaw & Co., Inc. 1.3% 1,902,685 +158% 0.02% $30,899,604
Aristotle Atlantic Partners, LLC 1.2% 1,842,444 -41% 1.4% $29,921,291
Blue Water Life Science Advisors, LP 1.2% 1,765,145 -18% 18% $28,665,955
DEUTSCHE BANK AG\ 1.1% 1,734,465 +1.2% 0.01% $28,167,711
PBU - The Pension Fund of Early Childhood & Youth Educators 1.1% 1,650,303 0% 1.8% $26,800,921

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 150,278,155 $2,440,576,416 +$33,609,697 $16.24 280
2025 Q3 145,446,098 $2,175,468,177 -$14,778,010 $14.96 269
2025 Q2 148,178,882 $1,726,248,551 -$46,396,273 $11.65 240
2025 Q1 152,930,142 $1,136,093,247 +$68,698,942 $7.43 222
2024 Q4 143,282,424 $858,588,192 +$3,881,916 $6.00 204
2024 Q3 143,105,692 $732,467,776 -$27,674,373 $5.12 184
2024 Q2 148,655,164 $538,029,201 +$26,127,842 $3.62 173
2024 Q1 142,447,362 $456,622,976 -$10,170,998 $3.21 186
2023 Q4 143,639,172 $703,966,709 +$9,702,761 $4.90 194
2023 Q3 140,492,459 $765,707,625 +$15,429,772 $5.45 187
2023 Q2 137,082,822 $919,786,637 +$21,850,661 $6.71 208
2023 Q1 133,849,942 $1,179,397,231 +$14,000,370 $8.83 223
2022 Q4 132,787,161 $1,014,264,343 +$14,824,828 $7.64 216
2022 Q3 131,007,037 $931,519,109 -$31,344,186 $7.12 205
2022 Q2 134,391,278 $1,083,708,756 +$49,040,887 $8.09 196
2022 Q1 125,563,937 $1,741,620,797 -$42,426,089 $13.88 207
2021 Q4 123,444,543 $3,462,001,567 +$139,816,088 $28.06 208
2021 Q3 117,860,461 $4,003,739,752 -$434,478 $33.99 212
2021 Q2 117,427,979 $4,796,005,013 +$143,202,294 $40.86 226
2021 Q1 113,768,226 $4,579,995,207 -$122,834,155 $40.26 238
2020 Q4 114,044,316 $6,743,577,628 +$149,068,690 $59.13 244
2020 Q3 111,322,127 $5,410,179,736 +$503,359,137 $48.63 206
2020 Q2 101,046,823 $4,886,712,149 +$212,566,003 $48.38 192
2020 Q1 96,830,392 $2,689,585,555 +$284,953,611 $27.78 144
2019 Q4 86,210,177 $2,579,382,908 +$148,626,753 $29.92 129
2019 Q3 81,041,176 $2,492,319,624 +$38,889,817 $30.90 116
2019 Q2 78,228,081 $3,735,247,853 +$3,731,000,860 $48.30 110
2019 Q1 103,941 $4,247,000 $40.86 1
2016 Q4 0 $0 -$10,117 $18.07 0
2016 Q3 235 $10,117 +$10,117 $43.05 1